17. Enabling ecosystems: data, insights, solutions
Insights
Cognitive &
Advanced Analytics
Data
Structured & Unstructured
Solutions
IBM & Ecosystem
Solutions
Individuals Researchers Gov’t Payers Providers
Human
ServicesPharma
IBM Watson Health Cloud
HIPAA-enabled, standards-based, scalable
Editor's Notes
When we talk about trends with our customers, overwhelming evidence points out the real need for change.
The population is aging, healthcare costs are rising and economic productivity improves when people’s health and social context are addressed.
These are only a few of the global trends but we know each country has a set of issues forcing the need to improve the health system.
We also know that different industries that are stakeholders in Health – with a capital H - see the same problems in different ways
http://www.euro.who.int/en/about-us/partners/observatory/activities/research-studies-and-projects/the-impact-of-financial-crisis-on-health-systems-in-europe
Case Study: MFTP funding in Ireland, started in 2014 “money follows the patient” , starting in hospitals, in future extending to primary care.
http://health.gov.ie/future-health/structural-reform-2/money-follows-the-patient/
Example: Ireland’s GNP fell by nearly 20% during the GFC between 2008 and 2011 while unemployment remained around 14%, requiring assistance from the ‘troika’ (EU, EU Central Bank and the IMF), with a key condition that public spending including healthcare be cut.
KEY MESSAGE: EFFICIENCY GAINS ARE NOT OPTIONAL – IT IS MANDATORY
http://www.whitehouse.gov/administration/eop/cea/TheEconomicCaseforHealthCareReform/
http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.pdf?ua=1
http://www.worldbank.org/en/publication/global-economic-prospects
To really improve Health we know we need an integrated approach to care that improves health and reduces costs.
We need to address the patient in full from wellness through late stages of life and be proactive on the approaches across the continuum of care.
With the acquisition of Phytel complementing the capabilities of IBM Care Management, we now have the capabilities to address the complete range of solutions targeting holistic care management specifically for vulnerable populations reduce costs and deliver better quality outcomes
Picture is quite telling of the problem
Where focus is today is that last chevron – better care and CHEAPER CARE
Emerging and growing rapidly is preventative care- proactive at the population level
To achieve holistic care across the care continuum for individuals, there clearly needs to be orchestration and collaboration amongst various stakeholder organizations – and the individual him/herself too.
The current marketplace of EMRs scores very poorly1
EMRs do not come close to meeting provider needs with respect to care coordination”2
It is not possible to bolt on functionality 2
Lack of standards for exchanging data3
Steep learning curves’ 3
‘Lack of role/responsibility agreement in EMRs’ 4
‘A need for central registries which do not exist today’ 5
‘Lack of defined outcomes for care plans’ 2
EMRs more often “forced workarounds” 3
Growing demand to manage information and cognitive overload
Patients want assurance of “no decision about me without me” 6
Lack of support for future care plans and goals, personalization and group decision making tools 7
Using an EMR for care coordination would be like using a database as an email system
http://www.euro.who.int/en/about-us/partners/observatory/activities/research-studies-and-projects/the-impact-of-financial-crisis-on-health-systems-in-europe
Case Study: MFTP funding in Ireland, started in 2014 “money follows the patient” , starting in hospitals, in future extending to primary care.
http://health.gov.ie/future-health/structural-reform-2/money-follows-the-patient/
Example: Ireland’s GNP fell by nearly 20% during the GFC between 2008 and 2011 while unemployment remained around 14%, requiring assistance from the ‘troika’ (EU, EU Central Bank and the IMF), with a key condition that public spending including healthcare be cut.
KEY MESSAGE: EFFICIENCY GAINS ARE NOT OPTIONAL – IT IS MANDATORY
The average person will generate 1,100 terabytes of data (vs. 6 terabytes of genomic data)
About 60% of data that determines health outcomes is exogenous – behavioral, socio-economic, etc. – and never captured as part of a person’s electronic medical records
This is “big data” in its traditional characteristics – volume, velocity, variety – and generated in uncontrolled environments
The generation/capture of this exogenous data is crucial for any emerging health ecosystems
All of this exogenous data is generated in uncontrolled environments (that is, no hospital or supply side control) – highly fragmented value chain that needs neutral entity that can collect, store, manage, curate, analyze data for insights
The ability to identify risk factors related to an adverse condition, e.g. heart failure diagnosis, very important for improving care quality and reducing cost
IBM working on a systematic approach to combine known risk factors with additional potential risk factors derived from data
So IBM saw the opportunity to make a significant difference and formed IBM Watson Health
Our CEO Ginni Rometty has called it IBM’s “moon shot” and an opportunity for the company to leave a significant legacy to enable transformation of the health ecosystem
IBM Watson Health
Approximately 2,000 dedicated employees, serving 500 hospitals and healthcare groups and over 300,000 providers
Partnerships: with Johnson & Johnson, Apple and Medtronic to create new offerings that leverage information collected from personal health, medical and fitness devices
Acquisitions: Explorys and Phytel two healthcare technology companies that are widely recognized for their leadership in applying big data and analytics to help improve the quality of health
Data Mart - HIPAA-compliant, standards-based, massively scalable open health data repository
Insights as a Service providing knowledge and actionable information through advanced analytics and cognitive capabilities
Health solutions from IBM and a an ecosystem of partners built on an open innovation platform to improve the overall health experience and quality of care delivered, when it matters and where it matters
***********
IBM is uniquely positioned to play a central role in healthcare transformation because:
Foundational technology components for a powerful platform
Advanced knowledge and data-driven analytics (Watson)
Leadership security, mobility and cloud technologies
IBM Research
Advanced semiconductors (small-scale sensor devices)
Genomics (analytics for drug repurposing)
Data-driven analytics for personalized healthcare
Partnering for market access and industry expertise
Trusted, non-aligned player
The Watson Health Cloud is the foundation. It will provide a secure and open platform for organizations across the care ecosystem to share health data, surface new insights and create new applications that address individuals’ needs at any stage of the care continuum with proactive, preventative and evidence-based approaches.
The new open platform will offer access to personal data of more than 50 million individuals in the US. This will expand to include populations from other nations as well. The information will be securely de-identified – or anonymized – then shared and combined with a dynamic and constantly growing aggregated view of clinical, health and social research data.
IBM and our ecosystem of clients, partners and medical researchers will be able to query this expanse of data to see new patterns, causalities and dependencies by surfacing new connections between diverse and previously siloed data sets.
Think of all the systems that track peoples’ personal information: EHRs, Physician Management Systems, Employment Records, Social Services Files, Claims Data, Clinical Trials, Academic Studies.
This will spur the creation of a new generation of data-driven applications and solutions designed to advance health and wellness.
Individuals and the larger cohorts or populations to which they belong will benefit. Providers will share and apply those insights in real-time to drive better, faster and less expensive treatments and more positive outcomes for individuals.